The development of a gene therapy for Friedreich’s ataxia receives €2.17 million in new public funding
The Spanish Ministry of Science, Innovation and Universities (MICIU) has awarded €1.7 million, and the European Commission an additional €466,000, to support the development of a gene therapy for Friedreich's ataxia by Biointaxis, a spin-off from IGTP.